ResMed (RMD) Stock Forecast & Price Target

ResMed
Bull Case

Here are some ways that investors could benefit from investing in ResMed Inc.:

• ResMed Inc. recently demonstrated strong financial performance by beating analyst expectations in its most recent quarterly report, posting earnings per share of $2.91 against a consensus estimate of $2.67, which signals robust operational execution and profitability that can drive shareholder value.
• The company maintains a conservative balance sheet with a debt-to-equity ratio of just 0.04, indicating minimal leverage and financial stability, which reduces the risk of insolvency and provides a strong foundation for long-term growth and dividend sustainability.
• ResMed Inc. offers a consistent income stream through its dividend, with a current yield of 1.12% and a payout ratio of 24.04%, meaning the company retains the majority of its earnings for reinvestment while still rewarding shareholders with regular cash distributions.
• Recent institutional activity shows renewed interest in the stock, as Mirae Asset Global Investments Co. Ltd. established a new position worth approximately $7.9 million in the third quarter, suggesting that large investors are recognizing the company's value and potential for recovery.
• With the current stock price at $233.87, ResMed Inc. trades at a P/E ratio of 20.45, which is reasonable for a healthcare equipment leader with a net margin of 27.79%, offering a potential entry point for investors seeking exposure to the sleep and respiratory care market.